A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma

by Roskos Lorin, Faggioni Raffaella, Molfino Nestor A, Kane Binita, Singh Dave, Woodcock Ashley
Published 2010-01-01